Pelthos Therapeutics Inc. (PTHS) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| License and Collaboration Revenue | 241K | FY2026-Q1 |
| Unique Prescribers for Zelsuvmi | 3.23K | FY2026-Q1 |
| Units Prescribed for Zelsuvmi | 7.88K | FY2026-Q1 |
| Zelsuvmi Units Dispensed | 7.88K | FY2026-Q1 |
| Net Product Revenue for Zelsuvmi | 9.09M | FY2025-Q4 |
Back to PTHS overview · PTHS earnings · PTHS holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.